"nonsmall cell lung cancer" trang 2 - tải miễn phí từ tailieunhanh
Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: A real-world study

Optimal therapy for concomitant EGFR and TP53 mutated non-small cell lung cancer: A real-world study
11    4    1
Membrane and DNA damaging/protective effects of eugenol, eucalyptol, terpinen-4-ol, and camphor at various concentrations on parental and drug-resistant H1299 cells

Membrane and DNA damaging/protective effects of eugenol, eucalyptol, terpinen-4-ol, and camphor at various concentrations on parental and drug-resistant H1299 cells
9    69    0
Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalinfixed paraffin-embedded tissue of nonsmall cell lung cancer

Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalinfixed paraffin-embedded tissue of nonsmall cell lung cancer
10    80    0
Personalized medicine for effective treatment of nonsmall-cell lung cancer with targeted therapiesa

Personalized medicine for effective treatment of nonsmall-cell lung cancer with targeted therapiesa
15    57    1
EGFR mutation status in Tunisian nonsmall-cell lung cancer patients evaluated by mutation-specific immunohistochemistry

EGFR mutation status in Tunisian nonsmall-cell lung cancer patients evaluated by mutation-specific immunohistochemistry
8    38    1
A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic nonsmall cell lung cancer and malignant pleural mesothelioma: Rationale and study protocol

A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic nonsmall cell lung cancer and malignant pleural mesothelioma: Rationale and study protocol
8    51    1
A randomized phase II study of radiation induced immune boost in operable nonsmall cell lung cancer (RadImmune trial)

A randomized phase II study of radiation induced immune boost in operable nonsmall cell lung cancer (RadImmune trial)
8    58    1
Aberrant splicing isoforms detected by fulllength transcriptome sequencing as transcripts of potential neoantigens in nonsmall cell lung cancer

Aberrant splicing isoforms detected by fulllength transcriptome sequencing as transcripts of potential neoantigens in nonsmall cell lung cancer
30    51    1
The potential of high-order features of routine blood test in predicting the prognosis of nonsmall cell lung cancer

The potential of high-order features of routine blood test in predicting the prognosis of nonsmall cell lung cancer
15    4    1
Combination of esomeprazole with chemotherapeutics results in more pronounced cytotoxic effect via apoptosis on A549 nonsmall-cell lung cancer cell line

Combination of esomeprazole with chemotherapeutics results in more pronounced cytotoxic effect via apoptosis on A549 nonsmall-cell lung cancer cell line
11    52    0
Efficacy of sorafenib in BRAF-mutated nonsmall-cell lung cancer (NSCLC) and no response in synchronous BRAF wild typehepatocellular carcinoma: A case report

Efficacy of sorafenib in BRAF-mutated nonsmall-cell lung cancer (NSCLC) and no response in synchronous BRAF wild typehepatocellular carcinoma: A case report
5    72    1
Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic nonsmall cell lung cancer TRAP OLIGO study (WJOG11118L)

Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic nonsmall cell lung cancer TRAP OLIGO study (WJOG11118L)
6    38    1
Treatment selection of early stage nonsmall cell lung cancer: The role of the patient in clinical decision making

Treatment selection of early stage nonsmall cell lung cancer: The role of the patient in clinical decision making
10    77    1
Báo cáo khoa học:

Báo cáo khoa học: " Validation of an elastic registration technique to estimate anatomical lung modification in NonSmall-Cell Lung Cancer Tomotherapy"
10    73    0
Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa nonsmall-cell lung cancer (NSCLC): The NEOMUN trial

Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa nonsmall-cell lung cancer (NSCLC): The NEOMUN trial
8    63    0
Báo cáo khoa học:

Báo cáo khoa học: "Large volume unresectable locally advanced nonsmall cell lung cancer: acute toxicity and initial outcome results with rapid arc"
9    97    0